Cargando…
Association between human blood metabolome and the risk of breast cancer
BACKGROUND: Breast cancer is the most common cancer among women with limited treatment options. To identify promising drug targets for breast cancer, we conducted a systematical Mendelian randomization (MR) study to screen blood metabolome for potential causal mediators of breast cancer and further...
Autores principales: | Wang, Yu, Liu, Fanghua, Sun, Lulu, Jia, Yiming, Yang, Pinni, Guo, Daoxia, Shi, Mengyao, Wang, Aili, Chen, Guo-Chong, Zhang, Yonghong, Zhu, Zhengbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872401/ https://www.ncbi.nlm.nih.gov/pubmed/36694207 http://dx.doi.org/10.1186/s13058-023-01609-4 |
Ejemplares similares
-
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer
por: Sun, Lulu, et al.
Publicado: (2022) -
Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study
por: Sun, Lulu, et al.
Publicado: (2023) -
Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
por: Xu, Qingyun, et al.
Publicado: (2023) -
Association Between Prekallikrein and Stroke: A Mendelian Randomization Study
por: Wang, Yinan, et al.
Publicado: (2023) -
Association of DNA Methylation in Blood Pressure-Related Genes With Ischemic Stroke Risk and Prognosis
por: Zhang, Huan, et al.
Publicado: (2022)